#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema X-linked lymphoproliferative syndrome Neuroendocrine tumour Fusarium infection Depression Follicular lymphoma stage I Acute leukaemia Extra-osseous Ewing's sarcoma MELAS syndrome Chronic lymphocytic leukaemia recurrent Immune-mediated myasthenia gravis Chemical burn Heavy menstrual bleeding Spinal cord injury Central nervous system lymphoma More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Basic Information Glycogen storage disease type V – Diagnostics Primary immunodeficiency syndrome – Treatment Piriformis syndrome – Basic Information Angiosarcoma – Diagnostics Haemophagocytic lymphohistiocytosis – Treatment Congenital nephrogenic diabetes insipidus Gaucher’s disease type I Chordoma – Basic Information Cholangitis sclerosing – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carcik-Cd19 Cells Arachis Hypogaea Flour Plerixafor Alnus Glutinosa Pollen ALE1 GSKVX000000046019 Vixarelimab Pyridoxine Hydrochloride Bp Rbl035.2 Setmelanotide CIRTUVIVINT Bi 1839100 Lenograstim Tecaginlimab 177Lu-Rhpsma-10.1 N-Acetylhistidine Pimecrolimus Oxytocin Synthetic Munc-T3 Neob More therapies…

    Learn about Your Condition

    Hypertrophic scar Plasma cell myeloma recurrent Oxygen saturation Breast proliferative changes Diabetic nephropathy Tympanic membrane perforation Laryngeal leukoplakia Hidradenitis Diffuse large B-cell lymphoma Bacteraemia Biliary tract disorder Tissue anoxia Schizoaffective disorder Mitochondrial DNA depletion Myocarditis post infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adenocarcinoma pancreas

  • Study on the Safety and Effectiveness of mFOLFIRINOX with or without BNT321 for Patients with Resected Pancreatic Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Human Igg1 Monoclobal Antibody Against Sialyl-Lewis A
    • Fluorouracil
    • Folinic Acid
    Denmark France Germany Spain

  • A Study of Saruparib for Patients with Metastatic Pancreatic Cancer with Homologous Repair Deficiency as First Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Saruparib
    France

  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • AZD4360
    Germany

  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Colorectal cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • AZD0022
    • Cetuximab
    Belgium Italy The Netherlands Poland Spain

  • Study on Survival in Patients with Resectable Pancreatic Cancer Using Irinotecan, Fluorouracil, Calcium Folinate, and Oxaliplatin Combination Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Irinotecan
    • Fluorouracil
    Spain

  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Head and neck cancer stage III
    • Head and neck cancer stage IV
    Investigated Drugs:
    • Tisotumab Vedotin
    • Carboplatin
    • Cisplatin
    France Germany Italy Spain
Previous Page
1 … 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!